Download PDF
Z Gastroenterol 2004; 42(12): 1408-1412
DOI: 10.1055/s-2004-813615
Kommentiertes Referat

© Karl Demeter Verlag im Georg Thieme Verlag KG Stuttgart · New York

Thalidomid: Antiangiogenetische Therapie bei gastrointestinalen Blutungen

Thalidomide for Treatment of Vascular MalformationsJ. Bauditz1 , H. H.-J Schmidt1 , H. Lochs1
  • 1Med. Klinik m. S. Gastroenterologie, Hepatologie und Endokrinologie, Charité Campus Mitte
Further Information

Publication History





Publication Date:
09 December 2004 (online)

Also available at
    Permissions and Reprints

Cirulli A, Liso A, D’Ovidio F et al. Vascular endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia. Acta Haematol. 2003; 110 (1): 29 - 32

Kurstin R. Using thalidomide in a patient with epithelioid leiomyosarcoma and Osler-Weber-Rendu disease. Oncology 2002; 16: 21 - 24

Perez-Encinas M, Rabunal Martinez MJ, Bello Lopez JL. Is thalidomide effective for the treatment of gastrointestinal bleeding in hereditary hemorrhagic telangiectasia? Haematologica 2002; 87: 34

Dr. Jürgen Bauditz

Med. Klinik m. S. Gastroenterologie, Hepatologie und Endokrinologie, Charité Campus Mitte

10117 Berlin